Cash & equivalents decreased 38.2%
Cash & equivalents changed -38.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -38.2% from the comparable as-filed period.
Inventory changed +42.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -115.7% from the comparable as-filed period.
Research & development changed -22.4% from the comparable as-filed period.
Stock-based compensation changed -17.7% from the comparable as-filed period.
Operating income changed -17.5% from the comparable as-filed period.
Operating margin changed -260 basis points from the comparable as-filed period.
Debt changed +0.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed -1.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.